New Alzheimer's drug will cost taxpayers billions, for limited effect
By Arthur Allen KFF Health News The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system […]
New Alzheimer's drug will cost taxpayers billions, for limited effect Read More »